GENMAB AS SP.ADR/1/10DK 1 (GE91) — Defensive Interval Ratio
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Defensive Interval Ratio of 284 days as of December 2025. Defensive assets of €1.11 Billion (cash €-, short-term investments €0.00, receivables €1.11 Billion) cover 284 days of daily cash needs of €3.91 Million/day. Check how tangible is GENMAB AS SP.ADR/1/10DK 1's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
GENMAB AS SP.ADR/1/10DK 1 Defensive Interval Ratio (2021–2025)
This chart shows how GENMAB AS SP.ADR/1/10DK 1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 284 days, meaning defensive assets of €1.11 Billion can fund 284 days of operations without new revenue. Also explore GE91 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for GENMAB AS SP.ADR/1/10DK 1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of GENMAB AS SP.ADR/1/10DK 1.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 284 days | €1.11 Billion | €3.91 Million/day | €- | €0.00 | ▼ -944 days |
| 2024 | 1228 days | €2.49 Billion | €2.03 Million/day | €- | €1.57 Billion | ▼ -1447 days |
| 2023 | 2675 days | €2.70 Billion | €1.01 Million/day | €- | €1.97 Billion | ▼ -958 days |
| 2022 | 3633 days | €2.61 Billion | €718.85K/day | €- | €1.79 Billion | ▲ +432 days |
| 2021 | 3200 days | €2.09 Billion | €653.99K/day | €- | €1.58 Billion | — |